Stealth Peptides Inc. Announces FDA IND Approval for Conduct of Clinical ... - Earthtimes (press release) |
![]() |
Earthtimes (press release)Bendavia is a new chemical entity that targets mitochondria to treat ischemia reperfusion injury, which commonly occurs with many cardiovascular, renal and ... read more |